Mikkel Vestergaard Olesen

Mikkel Vestergaard Olesen

Auto-generated profile, based on publicly available information

Mikkel Vestergaard Olesen

Centre for Neuroscience and Stereology, Copenhagen University Hospital Bispebjerg-Frederiksberg, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2011 in Behavioural Brain Research
Verified
Journal Article
Closed access
SCS.H. Christiansen
S.H. Christiansen
MOM.V. Olesen
M.V. Olesen
GWG. Wörtwein
G. Wörtwein
David WoldbyeDavid Woldbye
David Woldbye

5 August 2010 in Brain
Verified
Journal Article
Open access
PDF file
David WoldbyeDavid Woldbye
David Woldbye
MÄMikael Ängehagen
Mikael Ängehagen
Casper René GøtzscheCasper René Gøtzsche
Casper René Gøtzsche
HEHeidi Elbrønd-Bek
Heidi Elbrønd-Bek
ASAndreas T. Sørensen
Andreas T. Sørensen
MKMerab Kokaia
Merab Kokaia
Gene therapy using recombinant adeno-associated viral vectors overexpressing neuropeptide Y in the hippocampus exerts seizure-suppressant effects in rodent epilepsy models and is currently considered for clinical application in patients with intractable mesial temporal lobe epilepsy. Seizure suppression by neuropeptide Y in the hippocampus is predominantly mediated by Y2 receptors, which, together with neuropeptide Y, are upregulated after seizures as a compensatory mechanism. To explore whether such upregulation could prevent seizures, we overexpressed Y2 receptors in the hippocampus using recombinant adeno-associated viral vectors. In two temporal lobe epilepsy models, electrical kindling and kainate-induced seizures, vector-based transduction of Y2 receptor complementary DNA in the hippocampus of adult rats exerted seizure-suppressant effects. Simultaneous overexpression of Y2 and neuropeptide Y had a more pronounced seizure-suppressant effect. These results demonstrate that overexpression of Y2 receptors (alone or in combination with neuropeptide Y) could be an alternative strategy for epilepsy treatment.

31 October 2016 in Hippocampus
Verified
Journal Article
Closed access
PDF file
MOMikkel Vestergaard Olesen
Mikkel Vestergaard Olesen
GWGitta Wörtwein
Gitta Wörtwein
JFJonas Folke
Jonas Folke
BPBente Pakkenberg
Bente Pakkenberg

1 January 2012 in Neurobiology of Disease
Verified
Journal Article
Closed access
Casper René GøtzscheCasper René Gøtzsche
Casper René Gøtzsche
LNLitsa Nikitidou
Litsa Nikitidou
ASAndreas T. Sørensen
Andreas T. Sørensen
MOMikkel V. Olesen
Mikkel V. Olesen
GSGunnar Sørensen
Gunnar Sørensen
MKMerab Kokaia
Merab Kokaia

4 October 2011 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
MOM.V. Olesen
M.V. Olesen
SCS.H. Christiansen
S.H. Christiansen
Casper René GøtzscheCasper René Gøtzsche
Casper René Gøtzsche
LNL. Nikitidou
L. Nikitidou
MKM. Kokaia
M. Kokaia
David WoldbyeDavid Woldbye
David Woldbye

1 December 2005 in Brain Research
Verified
Journal Article
Closed access
MLM.H. Larsen
M.H. Larsen
MOM. Olesen
M. Olesen
David WoldbyeDavid Woldbye
David Woldbye
AHA. Hay-Schmidt
A. Hay-Schmidt
HHH.H. Hansen
H.H. Hansen
JMJ.D. Mikkelsen
J.D. Mikkelsen